Cullinan Oncology Inc.

NASDAQ: CGEM · Real-Time Price · USD
7.50
0.26 (3.59%)
At close: May 16, 2025, 3:59 PM
7.50
0.00%
After-hours: May 16, 2025, 04:20 PM EDT
3.59%
Bid 5.88
Market Cap 442.61M
Revenue (ttm) n/a
Net Income (ttm) -178.74M
EPS (ttm) -2.77
PE Ratio (ttm) -2.71
Forward PE -2.32
Analyst Buy
Ask 8
Volume 329,594
Avg. Volume (20D) 473,953
Open 7.23
Previous Close 7.24
Day's Range 7.22 - 7.63
52-Week Range 6.85 - 24.99
Beta -0.07

About CGEM

undefined

Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol CGEM
Website n/a
Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for CGEM stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts
3 months ago
+7.66%
Cullinan Therapeutics shares are trading higher af... Unlock content with Pro Subscription
7 months ago
+8.44%
Cullinan Therapeutics shares are trading higher after the FDA cleared the company's IND application for CLN-978.